PA
DOLE icon

PharVision Advisers’s Dole DOLE Stock Holding History

PharVision Advisers’s Portfolio DOLE Stock Details DOLE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,683
Closed -$175K – 259
2025
Q4 		$175K Buy
+11,683
New +$163K 0.09% 594
2025
Q3 		– Sell
-25,215
Closed -$353K – 694
2025
Q2 		$353K Buy
25,215
+8,362
+50% +$118K 0.51% 43
2025
Q1 		$244K Buy
+16,853
New +$233K 0.34% 143

Other funds holding DOLE

PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

PharVision Advisers's DOLE Position: Q1 2026 in Review

PharVision Advisers sold out of Dole (DOLE) in Q1 2026, closing a stake of 11,683 shares — an estimated $175K sold.

PharVision Advisers first reported a position in DOLE in Q1 2025 and held it in 3 quarters. The position peaked at $353K in Q2 2025. 216 funds tracked by Wall St. Rank hold DOLE as of Q1 2026.

  • PharVision Advisers reported no remaining Dole position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,683 Dole shares in Q1 2026, an estimated $175K.
  • PharVision Advisers first reported a position in Dole in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Dole position peaked at $353K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Dole as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.